Results 161 to 170 of about 2,116 (170)

Effectiveness of Dupilumab and Tralokinumab in Treating Nummular Eczema

International Journal of Dermatology
Francesca Barei, Alessandra Chiei Gallo, Roberto Pinto, Martina Zussino, Angelo V. Marzano, Silvia M. Ferrucci   +5 more
openaire   +2 more sources

Efficacy and safety of tralokinumab in the treatment of head and neck pattern atopic dermatitis: A multicentre study of 12 patients

Australasian Journal of Dermatology
Cintia Arjona Aguilera, Francisco José Navarro-Triviño   +1 more
exaly  

Tralokinumab unsuccessful for management of severe, uncontrolled asthma

The Lancet Respiratory Medicine, 2018
openaire   +2 more sources

A critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults

Expert Review of Clinical Immunology
Elena Pezzolo, Jacopo Tartaglia
exaly  

Effectiveness of abrocitinib for the treatment of moderate-to-severe atopic dermatitis in patients switched from dupilumab and/or tralokinumab: A real-world retrospective study

Journal of the American Academy of Dermatology
Mohannad Abu-Hilal
exaly  

Tralokinumab - Anti-IL13

Dermato Mag
openaire   +1 more source

Tralokinumab‐induced psoriasis relapse in a patient with atopic dermatitis

International Journal of Dermatology
Alessandra Chiei Gallo, Gianluca Tavoletti, Davide Termini, Angelo V. Marzano, Silvia M. Ferrucci   +4 more
openaire   +3 more sources

Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28‐Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE Levels

Allergy: European Journal of Allergy and Clinical Immunology
Daphne Bakker, Schuttelaar M L A, Marjolein de Bruin-Weller   +2 more
exaly  

TRALOKINUMAB DELIVERY DEVICE

2017
DOUGHTY DIANE, CLAWSON CORBIN, NARWAL ROJARAMANI, JAIN MEENA, DARDANI IAN P, HANSON IAN B, BENTE PAUL F, CICCIARELLI NICHOLAS J   +7 more
openaire   +1 more source

551 - Continuous tralokinumab treatment over 4 years in adults with moderate-to-severe atopic dermatitis provides long-term disease control

British Journal of Dermatology
exaly